Description

n-(3-Chloro-4-[1,3]Oxazolo[4,5-B]Pyridin-2-Ylphenyl)-2,3-Dihydro-1,4-Benzodioxine-6-Carboxamide is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, particularly for its potential role in modulating specific biological targets. It is primarily needed by pharmaceutical companies, biotechnology research firms, and academic institutions engaged in the synthesis of novel active pharmaceutical ingredients (APIs) and drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the multi-step synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Medicinal Chemistry Research: Used as a key scaffold or precursor for structure-activity relationship (SAR) studies to optimize potency, selectivity, and pharmacokinetic properties.
• Biochemical Probe Development: Employed in the design and creation of chemical probes for investigating enzyme function and cellular signaling pathways in biological research.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for client-sponsored drug discovery projects.
• Academic Synthesis Studies: Utilized in university laboratories for methodological development and teaching advanced organic synthesis techniques involving fused heterocycles.

Basic Information

Item	Detail
Product Name	n-(3-Chloro-4-[1,3]Oxazolo[4,5-B]Pyridin-2-Ylphenyl)-2,3-Dihydro-1,4-Benzodioxine-6-Carboxamide
CAS No.	929971-00-6
Molecular Formula	C23H16ClN3O4
Molecular Weight	433.84 g/mol
Synonyms	929971-00-6; 2,3-Dihydro-1,4-benzodioxine-6-carboxamide, N-[3-chloro-4-[1,3]oxazolo[4,5-b]pyridin-2-yl]phenyl]-; N-(3-Chloro-4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide; BDB Carboxamide Derivative; Oxazolopyridine-Benzodioxine Carboxamide
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the exacting standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting purity, related substances, and residual solvents.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC/MS)	Conforms
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.